[Relationship between proteoglycans and apoE on the HepG2 cell surface]

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2001 Aug;23(4):320-3.
[Article in Chinese]

Abstract

Objective: To characterize the associations and functions of apoE with the HepG2 cell surface through the study of the relationship between proteoglycans and apoE on HepG2 cell surface.

Methods: The specific binding of 7C9, a monoclonal antibody against the N-terminal domain of apoE was employed to demonstrate the effects of glycosaminoglycans, heparinase, chondroitinase, xyloside, and chlorate on the apoE of HepG2 cell surface.

Results: Growth of cells in beta-D-xyloside decreased cell surface apoE by 45% with a concomitant increase in apoE secretion (4.3-fold), underlining the importance of glycosaminoglycan association of apo E. Incubations with heparinase (3 U/ml) and heparin (1 mg/ml) decreased apoE by 25.0% and 30.5% respectively indicating association through cell surface haparin sulfate proteoglycans. Incubations with chondroitinase ABC (1.5 U/ml) reduced cell surface apoE by 40.0%. Chondroitin sulfate A and chondroitin sulfate B reduced cell surface apoE by 23.6% and 15.3% respectively while incubations with chondrointin sulfate C not effective. Decreasing the levels of cell surface apoE with haparin or chondrointin sulfates A and B increased the subsequent binding of LDL to the HepG2 cell surface.

Conclusions: ApoE associates with the cell surface mainly through chondrointin sulfate proteoglycans and to a lesser extent through heparan sulfate proteoglycans, decreased levels of cell surface apoE increase the binding of LDL to the cell surface.

Publication types

  • English Abstract

MeSH terms

  • Apolipoproteins E / metabolism*
  • Carcinoma, Hepatocellular / metabolism*
  • Carcinoma, Hepatocellular / pathology
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Glycosaminoglycans / pharmacology
  • Glycosides / pharmacology
  • Heparin Lyase / pharmacology
  • Humans
  • Lipoproteins, LDL / metabolism
  • Liver Neoplasms / metabolism*
  • Liver Neoplasms / pathology
  • Proteoglycans / pharmacology*
  • Tumor Cells, Cultured

Substances

  • Apolipoproteins E
  • Glycosaminoglycans
  • Glycosides
  • Lipoproteins, LDL
  • Proteoglycans
  • xylosides
  • Heparin Lyase